[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 15, 1974

Pure RBC Aplasia and Diphenylhydantoin

Author Affiliations

From the Section of Hematology, Department of Medicine, St. Elizabeth Hospital, Youngstown, Ohio.

JAMA. 1974;229(3):314-315. doi:10.1001/jama.1974.03230410038021

Two patients developed pure red blood cell (RBC) aplasia while taking diphenylhydantoin sodium; one had concurrent acute viral hepatitis. Whether these patients had pure RBC aplasia secondary to diphenylhydantoin use or whether viral hepatitis or drugs other than diphenylhydantoin played a role cannot be decided. The facts that (1) the cases reported in association with acute viral hepatitis have all been a true aplastic anemia, (2) the drugs other than diphenylhydantoin used in these patients have never been reported to cause pure RBC aplasia, and (3) our patients recovered completely with cessation of diphenylhydantoin therapy and initiation of steroid therapy, led us to believe that diphenylhydantoin was the most likely cause.

(JAMA 229:314-315, 1974)